Risk Factors for Refeeding Syndrome in the Surgical Intensive Care Unit
1 other identifier
observational
60
1 country
1
Brief Summary
Refeeding Syndrome is a condition that occurs when patients who are undernourished or undernourished suddenly start overfeeding, causing electrolyte disturbances and vitamin deficiencies, resulting in neurological and cardiac problems. It may even result in death. It is aimed to prevent the development of Refeeding Syndrome with nutrition in accordance with the guidelines. The aim of this study is to determine the risk factors for Refeeding Syndrome in Intensive Care Unit (ICU).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jun 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 9, 2023
CompletedFirst Submitted
Initial submission to the registry
September 19, 2023
CompletedFirst Posted
Study publicly available on registry
September 26, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 9, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
July 9, 2024
CompletedSeptember 26, 2023
September 1, 2023
1 year
September 19, 2023
September 19, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Occurrence of Refeeding Syndrome
Occurrence of RFS：Within 72 hours after feeding serum phosphorus \< 0.0.87mmol/L, or from the baseline levels drop \> 0.16% or drop \> 30%;And (or) hypokalemia, hypomagnesemia, hypocalcemia and corresponding clinical symptoms
from june 9, 2023 to june 9, 2024
Study Arms (1)
the treated patients in ICU
Patients receiving nutrition while receiving treatment in intensive care
Interventions
Patients who developed Refeeding Syndrome despite proper nutrition while receiving treatment in the ICU
Eligibility Criteria
Adult patients receiving treatment in intensive care at Samsun University Hospital
You may qualify if:
- Patients are intensive care patients
- Patients' age \> 18 -
You may not qualify if:
- Diabetic ketoacidosis
- Other risk factors for hypophosphatemia (patients on continuous hemodialysis, hyperphosphatemia treatment, parathyroidectomy)
- Patients with pre-study hypophosphatemia (\< 0.65 mmol/L)
- Patients with hyperparathyroidism
- Terminal stage cancer patients
- Patients with Glasgow Coma Scale ≤5
- Patients with respiratory and metabolic alkalosis -
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Şerife Seçgin
Samsun, 55270, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
ÖZGÜR KÖMÜRCÜ
SAMSUN UNIVERSITY HOSPITAL
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Specialist of Anaesthesiology and Reanimation Principle İnvestigator
Study Record Dates
First Submitted
September 19, 2023
First Posted
September 26, 2023
Study Start
June 9, 2023
Primary Completion
June 9, 2024
Study Completion
July 9, 2024
Last Updated
September 26, 2023
Record last verified: 2023-09